Saturday, August 23, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Maintain Hold Rating with Moderate Upside for Goosehead Insurance

Elaine Mendonca by Elaine Mendonca
January 31, 2024
in Breaking News
0
Gas Utilities stock Trading
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On January 31, 2024, Truist Securities analyst Mark Hughes decided to maintain a Hold rating on Goosehead Insurance (NASDAQ: GSHD) while increasing the price target from $65 to $75. This adjustment aligns with the general consensus of other analysts, who have an average price target of $78.25 based on 8 Wall Street analysts’ 12-month price targets over the past 3 months. It’s worth noting that the highest analyst price target stands at $100.00, while the lowest forecast is $41.00. Furthermore, the average stock forecast for Goosehead Insurance Inc (GSHD) is $81.15, indicating a potential upside of 16.54%. Overall, analysts seem to agree on a moderate upside for Goosehead Insurance.

GSHD Stock Drops by 2.70% on January 31, Contradicting Previous Positive Performance: Investors and Analysts Await Further Developments

On January 31, 2024, GSHD stock dropped by $2.14, representing a 2.70% decrease from the previous market close. The stock closed at $77.20 on that day. The stock’s performance did not change in after-hours trading, suggesting no significant movement or reaction to the day’s events after the market closed. This decline in share price on January 31 contradicts the stock’s previous positive performance, trading near the top of its 52-week range and above its 200-day simple moving average. Investors and analysts may want to monitor the stock’s performance in the coming days to see if this decline continues or if it rebounds.

GSHD Stock Performance on January 31, 2024: Revenue Increases, Net Income Decreases

On January 31, 2024, GSHD stock showcased a mixed performance in terms of its revenue and income figures. The company’s total revenue for the past year stood at $209.39 million, indicating a 38.38% increase since the previous year. However, the net income for GSHD amounted to $565,000, representing a significant 89.54% decrease since the previous year. The earnings per share (EPS) stood at $0.03 for the past year, reflecting an 89.98% decrease since the previous year. Despite the decline in net income, it experienced a substantial increase since the last quarter. The EPS figures also showed a significant decrease since the previous year but a noteworthy increase since the last quarter. Overall, GSHD’s stock performance on January 31, 2024, demonstrates a combination of positive and negative factors, and investors will closely monitor the company’s future financial reports to gain a clearer understanding of its performance and prospects.

Tags: GSHD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Analyst Ratings and Price Targets for Helmerich Payne HP Stock

Finance_Assets

Arrow Financial Corporation Experiences Decline in Q4 GAAP EPS and Cash Reserves

Finance_Capitalization

StoneCo NASDAQ STNE Downgraded to Neutral by UBS Analyst with Revised Price Target

Recommended

Biotechnology Market Capitalization

BioAffinity Technologies Resumes Trading on Stock Market What Investors Need to Know

1 year ago
Finance_Commercial (2)

Lack of Information on Rosenblatts Analysis and Price Target for Sonos

2 years ago
Food Producers Stock Bull Market

Analyst Reiterates Buy Rating and Maintains Price Target for The Chefs Warehouse

2 years ago

Alterity Therapeutics Phase 2 Clinical Trial for Potential MSA Remedy Receives Approval

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN Apple AVGO BA C CELH COIN Coinbase COST CRWD CTVA DELL DFS DIS DWAC Eli Lilly EQT GM GRFS IBM INTC JPM LLY META MSFT NFLX NIO NVDA NVO PARA PLTR PLUG SMCI Strategy TGT TSLA UNH VZ
No Result
View All Result

Highlights

Financial Sector Rallies on Dovish Federal Reserve Signals

MediaAlpha Navigates Record Revenue Amid Regulatory Challenges

Office Furniture Sector Transformed by Major Acquisition Deal

CF Industries Navigates Strong Earnings Amid Cost Challenges

Acquisition Battle Intensifies for International Money Express

Mitek Shares: Technical Excellence Meets Valuation Concerns

Trending

Plymouth Industrial Reit Stock
Stocks

Acquisition Interest Sparks Analyst Reevaluation of Plymouth Industrial REIT

by Dieter Jaworski
August 23, 2025
0

The industrial real estate sector is witnessing a fascinating development as Plymouth Industrial REIT finds itself at...

Immunovant Inc Stock

Immunovant’s Critical Juncture: All Eyes on September Catalyst

August 23, 2025
Figs Stock

Healthcare Apparel Stock Faces Diverging Signals: Institutional Buys Versus Insider Sales

August 23, 2025
Northern Stock

Financial Sector Rallies on Dovish Federal Reserve Signals

August 23, 2025
Mediaalpha Stock

MediaAlpha Navigates Record Revenue Amid Regulatory Challenges

August 23, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Acquisition Interest Sparks Analyst Reevaluation of Plymouth Industrial REIT August 23, 2025
  • Immunovant’s Critical Juncture: All Eyes on September Catalyst August 23, 2025
  • Healthcare Apparel Stock Faces Diverging Signals: Institutional Buys Versus Insider Sales August 23, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com